Sex Differences in the Primary Prevention of Cardiovascular Diseases in a Dutch Primary Care Setting
References
- Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. Journal of the American College of Cardiology. 2017 Jul 4; 70(1): 1–25. DOI: 10.1016/j.jacc.2017.04.052
- Global Burden of Disease Study 2019 (GBD 2019) Data Resources | GHDx [Internet]. [cited 2023 Apr 4]. Available from:
https://ghdx.healthdata.org/gbd-2019 . - Appelman Y, van Rijn BB, ten Haaf ME, Boersma E, Peters SAE. Sex differences in cardiovascular risk factors and disease prevention. Atherosclerosis. 2015 Jul 1; 241(1): 211–8. DOI: 10.1016/j.atherosclerosis.2015.01.027
- Vogel B, Acevedo M, Appelman Y, Merz CNB, Chieffo A, Figtree GA, et al. The Lancet women and cardiovascular disease commission: Reducing the global burden by 2030. The Lancet. 2021 Jun 19; 397(10292): 2385–438. DOI: 10.1016/S0140-6736(21)00684-X
- Mosca L, Barrett-Connor E, Wenger NK. Sex/gender differences in cardiovascular disease prevention: What a difference a decade makes. Circulation. 2011 Nov 8; 124(19): 2145–54. DOI: 10.1161/CIRCULATIONAHA.110.968792
- Peters SAE, Huxley RR, Woodward M. Diabetes as risk factor for incident coronary heart disease in women compared with men: A systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia. 2014 Aug 1; 57(8): 1542–51. DOI: 10.1007/s00125-014-3260-6
- Garcia M, Mulvagh SL, Bairey Merz CN, Buring JE, Manson JE. Cardiovascular disease in women. Circulation Research. 2016 Apr 15; 118(8): 1273–93. DOI: 10.1161/CIRCRESAHA.116.307547
- Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). European Heart Journal. 2016 Aug 1; 37(29): 2315–81. DOI: 10.1093/eurheartj/ehw106
- Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC). European Heart Journal. 2021 Sep 7; 42(34): 3227–337. DOI: 10.1093/eurheartj/ehab484
- Hyun KK, Redfern J, Patel A, Peiris D, Brieger D, Sullivan D, et al. Gender inequalities in cardiovascular risk factor assessment and management in primary healthcare. Heart. 2017 Apr 1; 103(7): 492–8. DOI: 10.1136/heartjnl-2016-310216
- Xia S, Du X, Guo L, Du J, Arnott C, Lam CSP, et al. Sex differences in primary and secondary prevention of cardiovascular disease in China. Circulation. 2020 Feb 18; 141(7): 530–9. DOI: 10.1161/CIRCULATIONAHA.119.043731
- Jong M de, Vos RC, Ritter R de, Kallen CJ van der, Sep SJ, Woodward M, et al. Sex differences in cardiovascular risk management for people with diabetes in primary care: a cross-sectional study. BJGP Open [Internet]. 2019 Jul 1 [cited 2023 Apr 4]; 3(2). Available from:
https://bjgpopen.org/content/3/2/bjgpopen19X101645 . - Zhao M, Vaartjes I, Graham I, Grobbee D, Spiering W, Klipstein-Grobusch K, et al. Sex differences in risk factor management of coronary heart disease across three regions. Heart. 2017 Oct 1; 103(20): 1587–94. DOI: 10.1136/heartjnl-2017-311429
- Koopman C, Vaartjes I, van Dis I, Verschuren WMM, Engelfriet P, Heintjes EM, et al. Explaining the decline in coronary heart disease mortality in the Netherlands between 1997 and 2007. PLoS One. 2016 Jan 1; 11(12):
e0166139 . DOI: 10.1371/journal.pone.0166139 - van Lieshout J, Wensing M, Campbell SM, Grol R. Primary care strength linked to prevention programs for cardiovascular disease. Am J Manag Care. 2009 Apr; 15(4): 255–62.
- Leening MJG, Siregar S, Vaartjes I, Bots ML, Versteegh MIM, van Geuns RJM, et al. Heart disease in the Netherlands: A quantitative update. Neth Heart J. 2014 Jan; 22(1): 3–10. DOI: 10.1007/s12471-013-0504-x
- Smeets HM, Kortekaas MF, Rutten FH, Bots ML, van der Kraan W, Daggelders G, et al. Routine primary care data for scientific research, quality of care programs and educational purposes: The Julius General Practitioners’ Network (JGPN). BMC Health Serv Res. 2018 Sep 25; 18: 735. DOI: 10.1186/s12913-018-3528-5
- Cardiovasculair risicomanagement (CVRM) | NHG-Richtlijnen [Internet]. [cited 2023 Apr 4]. Available from:
https://richtlijnen.nhg.org/multidisciplinaire-richtlijnen/cardiovasculair-risicomanagement-cvrm . - Rachamin Y, Grischott T, Rosemann T, Meyer MR. Inferior control of low-density lipoprotein cholesterol in women is the primary sex difference in modifiable cardiovascular risk: A large-scale, cross-sectional study in primary care. Atherosclerosis. 2021 May 1; 324: 141–7. DOI: 10.1016/j.atherosclerosis.2021.02.024
- Banks E, Welsh J, Joshy G, Martin M, Paige E, Korda RJ. Comparison of cardiovascular disease risk factors, assessment and management in men and women, including consideration of absolute risk: A nationally representative cross-sectional study. BMJ Open. 2020 Dec 1; 10(12):
e038761 . DOI: 10.1136/bmjopen-2020-038761 - Boer AR de, Hollander M, Dis I van, Visseren FL, Bots ML, Vaartjes I. Blood pressure and cholesterol measurements in primary care: Cross-sectional analyses in a dynamic cohort. BJGP Open [Internet]. 2022 Jun 1 [cited 2023 Apr 4]; 6(2). Available from:
https://bjgpopen.org/content/6/2/BJGPO.2021.0131 . - Höhn A, Gampe J, Lindahl-Jacobsen R, Christensen K, Oksuyzan A. Do men avoid seeking medical advice? A register-based analysis of gender-specific changes in primary healthcare use after first hospitalisation at ages 60+ in Denmark. J Epidemiol Community Health. 2020 Jun; 74(7): 573–9. DOI: 10.1136/jech-2019-213435
- Wang Y, Hunt K, Nazareth I, Freemantle N, Petersen I. Do men consult less than women? An analysis of routinely collected UK general practice data. BMJ Open. 2013 Aug 1; 3(8):
e003320 . DOI: 10.1136/bmjopen-2013-003320 - Hunt K, Ford G, Harkins L, Wyke S. Are women more ready to consult than men? Gender differences in family practitioner consultation for common chronic conditions. Journal of Health Services Research & Policy. 1999; 4(2): 96–100. DOI: 10.1177/135581969900400207
- Peters SAE, Muntner P, Woodward M. Sex differences in the prevalence of, and trends in, cardiovascular risk factors, treatment, and control in the United States, 2001 to 2016. Circulation. 2019 Feb 19; 139(8): 1025–35. DOI: 10.1161/CIRCULATIONAHA.118.035550
- Pinho-Gomes AC, Peters SAE, Thomson B, Woodward M. Sex differences in prevalence, treatment and control of cardiovascular risk factors in England. Heart. 2020 Sep 4. DOI: 10.1136/heartjnl-2020-317446
- Palmisano BT, Zhu L, Eckel RH, Stafford JM. Sex differences in lipid and lipoprotein metabolism. Molecular Metabolism. 2018 Sep 1; 15: 45–55. DOI: 10.1016/j.molmet.2018.05.008
- Samargandy S, Matthews KA, Brooks MM, Barinas-Mitchell E, Magnani JW, Janssen I, et al. Abdominal visceral adipose tissue over the menopause transition and carotid atherosclerosis: The SWAN heart study. Menopause. 2021 Mar 1; 28(6): 626–33. DOI: 10.1097/GME.0000000000001755
- Nanna MG, Wang TY, Xiang Q, Goldberg AC, Robinson JG, Roger VL, et al. Sex differences in the use of statins in community practice. Circulation: Cardiovascular Quality and Outcomes. 2019 Aug; 12(8):
e005562 . DOI: 10.1161/CIRCOUTCOMES.118.005562 - Zhao M, Woodward M, Vaartjes I, Millett ERC, Klipstein-Grobusch K, Hyun K, et al. Sex differences in cardiovascular medication prescription in primary care: A systematic review and meta-analysis. J Am Heart Assoc. 2020 Jun 1; 9(11):
e014742 . DOI: 10.1161/JAHA.119.014742 - Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 2010 May 26; 303(20): 2043–50. DOI: 10.1001/jama.2010.650
- Qvarnström M, Wettermark B, Ljungman C, Zarrinkoub R, Hasselström J, Manhem K, et al. Antihypertensive treatment and control in a large primary care population of 21 167 patients. J Hum Hypertens. 2011 Aug; 25(8): 484–91. DOI: 10.1038/jhh.2010.86
- Klungel OH, de Boer A, Paes AH, Seidell JC, Bakker A. Sex differences in antihypertensive drug use: determinants of the choice of medication for hypertension. J Hypertens. 1998 Oct; 16(10): 1545–53. DOI: 10.1097/00004872-199816100-00021
- Chou AF, Scholle SH, Weisman CS, Bierman AS, Correa-de-Araujo R, Mosca L. Gender disparities in the quality of cardiovascular disease care in private managed care plans. Womens Health Issues. 2007; 17(3): 120–30. DOI: 10.1016/j.whi.2007.03.002
- Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials. The Lancet. 2015 Apr 11; 385(9976): 1397–405. DOI: 10.1016/S0140-6736(14)61368-4
- Kostis WJ, Cheng JQ, Dobrzynski JM, Cabrera J, Kostis JB. Meta-analysis of statin effects in women versus men. J Am Coll Cardiol. 2012 Feb 7; 59(6): 572–82. DOI: 10.1016/j.jacc.2011.09.067
- Bots SH, Onland-Moret NC, Jancev M, Hollander M, Tulevski II, Hofstra L, et al. Statins are associated with a large reduction in all-cause mortality in women from a cardiac outpatient population. Open Heart. 2022 Apr 20; 9(1):
e001900 . DOI: 10.1136/openhrt-2021-001900 - Tamargo J, Rosano G, Walther T, Duarte J, Niessner A, Kaski J, et al. Gender differences in the effects of cardiovascular drugs. European Heart Journal – Cardiovascular Pharmacotherapy. 2017 Jul 1; 3(3): 163–82. DOI: 10.1093/ehjcvp/pvw042
- Reith C, Baigent C, Blackwell L, Emberson J, Spata E, Davies K, et al. Effect of statin therapy on muscle symptoms: An individual participant data meta-analysis of large-scale, randomised, double-blind trials. The Lancet. 2022 Sep 10; 400(10355): 832–45. DOI: 10.1016/S0140-6736(22)01545-8
- Manteuffel M, Williams S, Chen W, Verbrugge RR, Pittman DG, Steinkellner A. Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines. Journal of Women’s Health. 2014 Feb; 23(2): 112–9. DOI: 10.1089/jwh.2012.3972
- Olmastroni E, Boccalari MT, Tragni E, Rea F, Merlino L, Corrao G, et al. Sex-differences in factors and outcomes associated with adherence to statin therapy in primary care: Need for customisation strategies. Pharmacol Res. 2020 May; 155: 104514. DOI: 10.1016/j.phrs.2019.104514
- Santema BT, Ouwerkerk W, Tromp J, Sama IE, Ravera A, Regitz-Zagrosek V, et al. Identifying optimal doses of heart failure medications in men compared with women: A prospective, observational, cohort study. The Lancet. 2019; 394(10205): 1254–63. DOI: 10.1016/S0140-6736(19)31792-1
- Zucker I, Prendergast BJ. Sex differences in pharmacokinetics predict adverse drug reactions in women. Biology of Sex Differences. 2020 Jun 5; 11(1): 32. DOI: 10.1186/s13293-020-00308-5
- Leporini C, De Sarro G, Russo E. Adherence to therapy and adverse drug reactions: Is there a link? Expert opinion on drug safety. 2014; 13(sup1): 41–55. DOI: 10.1517/14740338.2014.947260
DOI: https://doi.org/10.5334/gh.1284 | Journal eISSN: 2211-8179
Language: English
Submitted on: Apr 4, 2023
Accepted on: Dec 4, 2023
Published on: Jan 19, 2024
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
© 2024 Pauline A. J. Kiss, Alicia Uijl, Estefania Betancur, Annemarijn R. de Boer, Diederick E. Grobbee, Monika Hollander, Charlotte N. Onland-Moret, Miriam C. J. M. Sturkenboom, Sanne A. E. Peters, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.